These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35454034)

  • 41. MRI and CT in the follow-up after irreversible electroporation of small renal masses.
    Buijs M; de Bruin DM; Wagstaff PG; J Zondervan P; Scheltema MJ; W Engelbrecht M; P Laguna M; van Lienden KP
    Diagn Interv Radiol; 2021 Sep; 27(5):654-663. PubMed ID: 34559050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel software platform for volumetric assessment of ablation completeness.
    Solbiati M; Muglia R; Goldberg SN; Ierace T; Rotilio A; Passera KM; Marre I; Solbiati L
    Int J Hyperthermia; 2019; 36(1):337-343. PubMed ID: 30729818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone.
    Vogl TJ; Basten LM; Nour-Eldin NA; Kaltenbach B; Bodelle B; Wichmann JL; Ackermann H; Naguib NNN
    Int J Hyperthermia; 2018 Jun; 34(4):492-500. PubMed ID: 28774210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile.
    Chen X; Ren Z; Yin S; Xu Y; Guo D; Xie H; Zhou L; Wu L; Jiang J; Li H; Sun J; Zheng S
    Cytokine; 2017 May; 93():44-50. PubMed ID: 28506570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microwave ablation
    Dou J; Cheng Z; Han Z; Liu F; Wang Z; Yu X; Yu J; Liang P
    Cancer Biol Med; 2021 Sep; 19(7):1078-88. PubMed ID: 34586759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4-8-Week Postablation Assessment.
    Zirakchian Zadeh M; Sotirchos VS; Kirov A; Lafontaine D; Gönen M; Yeh R; Kunin H; Petre EN; Kitsel Y; Elsayed M; Solomon SB; Erinjeri JP; Schwartz LH; Sofocleous CT
    J Vasc Interv Radiol; 2024 Apr; 35(4):523-532.e1. PubMed ID: 38215818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
    Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection.
    Adwan H; Hammann L; Vogl TJ
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion.
    Li Z; Jiao D; Si G; Han X; Zhang W; Li Y; Zhou X; Liu J; Li J; Liu Z
    Int J Hyperthermia; 2021; 38(1):428-436. PubMed ID: 33691589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images.
    Jia ZY; Chen QF; Yang ZQ; Wu WT; Shi HB; Liu S
    Abdom Radiol (NY); 2017 Jun; 42(6):1781-1787. PubMed ID: 28180923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
    Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
    Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases.
    Liu C; He J; Li T; Hong D; Su H; Shao H
    Abdom Radiol (NY); 2021 May; 46(5):2161-2172. PubMed ID: 33108496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.
    Figini M; Zhou K; Pan L; Sun C; Wang B; Hu S; Yang J; Shangguan J; Eresen A; Velichko Y; Yaghmai V; Zhang Z
    Magn Reson Med; 2020 Jul; 84(1):365-374. PubMed ID: 31850550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Irreversible Electroporation For Liver Tumors: A Review Of Literature.
    Tameez Ud Din A; Tameez-Ud-Din A; Chaudhary FMD; Chaudhary NA; Siddiqui KH
    Cureus; 2019 Jun; 11(6):e4994. PubMed ID: 31497425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cone beam computed tomography-guided microwave ablation for hepatocellular carcinoma under the hepatic dome: a retrospective case-control study.
    Liu Y; Wu K; Xu K; Tian C; Jiao D; Han X
    Quant Imaging Med Surg; 2022 Oct; 12(10):4837-4851. PubMed ID: 36185058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination Therapy of Bland Transarterial Embolization and Microwave Ablation for Hepatocellular Carcinoma within the Milan Criteria Leads to Significantly Higher Overall Survival.
    Adwan H; Adwan M; Vogl TJ
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
    Mukund A; Vats P; Jindal A; Patidar Y; Sarin SK
    J Clin Exp Hepatol; 2020; 10(6):563-573. PubMed ID: 33311893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not?
    Ding J; Zhou Y; Wang Y; Jing X; Wang F; Wang Y
    Liver Int; 2017 Sep; 37(9):1365-1372. PubMed ID: 28319345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.